No....did you not listen to the briefing?
They do not know why the question has arisen, so how do you get no impressions given. It might be just a few things, no-one knows.
Actavis are standing by QRX it seems.
Just post facts, it's not an oiler duster for gods sake.
The FDA had many chances to tell QRX of any combination concerns, nothing was said. QRX has additonal data not seen by the FDA yet.
No....did you not listen to the briefing?They do not know why...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
